NAFOSTED
The National Foundation for Science and Technology Development (NAFOSTED) is a funding agency that supports basic research, applied research, and urgent science and technology (S&T) projects of significant scientific and practical importance, as well as potential S&T tasks and activities aimed at strengthening national scientific and technological capacity.
2025 (11)
[1] Nanotechnology application for formulation of immediate release and sustained-release capsules/tablets containing poorly soluble drugs
PI. Prof. Dr. Nguyen Ngoc Chien - MS: 108.05-2024.11 – Level: Nafosted - Time: 2025 – 2027
[2] Design, synthesis, biological evaluation of novel multitargeted compounds as potential agents for treatment of Alzheimer disease.
PI. Assoc. Prof. Dr. Tran Thi Phuong Thao – MS: 108.05-2024.04 – Level: Nafosted – Time: 2025 – 2027
[3] Design and development of indolin-2-one conjugated indolin-2-one derivatives with fluorescence detectors for applications in cancer diagnosis and treatment.
PI. Dr. Luong Thi Thanh Huyen – MS: 104.01-2025.69 – Level: Nafosted – Time: 2025 – 2028
[4] This study assesses the levels of antibiotic residue contamination and antibiotic resistance genes in wastewater and sludge in Vietnam.
PI. Assoc. Prof. Dr. Nguyen Thi Kieu Anh – MS: 105.99-2025.30 – Level: Nafosted – Time: 2025 – 2029
[5] Design, synthesis, and evaluation of the anticancer effects of novel benzimidazole derivatives targeting Bcl2 inhibition.
PI. Dr. Nguyen Cong Truong – MS: 108.99-2025.71 – Level: Nafosted – Time: 2025 – 2028
[6] Research on developing immune checkpoint inhibitors targeting IDO1 for application in cancer immunotherapy.
PI. Dr. Pham Duc Vinh – MS: 108.05-2025.15 – Level: Nafosted – Time: 2025 – 2028
[7] The Suzuki coupling reaction was used to synthesize several novel heterocyclic derivatives with potential for cancer treatment through inhibition of the enzyme histone deacetylase.
PI. Dr. Duong Tien Anh – MS: 104.01-2025.33 – Level: Nafosted – Time: 2025 – 2028
[8] Research on the development of several injectable extended-release drug delivery systems for goserelin acetate.
PI. Assoc. Prof. Dr. Tran Thi Hai Yen – MS: 39/2025/TN – Level: Nafosted – Time: 2026 – 2029
[9] Research on the formulation and ocular bioavailability of in-situ hydrogels containing antibiotic nanoparticles for application in ophthalmic treatment.
PI. Dr. Tran Ngoc Bao – MS: 108.05-2025.138 – Level: Nafosted – Time: 2026 – 2029
[10] Development of a sublingual, sublingual, targeted brain delivery system using a single-walled, multifunctional carbon tube for delivering drugs in the treatment of Alzheimer's disease.
PI. Dr. Le Thi Thu Hoa – MS: 108.05-2025.211 – Level: Nafosted – Time: 2026 – 2029
[11] Developing a precise drug dosing tool based on population pharmacokinetics, utilizing artificial intelligence and adaptive Bayesian algorithms, integrated with an electronic medical record system for use on Vietnamese patients.
PI.Assoc. Prof. Dr. Nguyen Thi Lien Huong – MS: NCUD.07-2025.53 – Level: Nafosted – Time: 2026 – 2029
2024 (05)
[1] Design, synthesis and evaluation of antitumor activity of some novel series as inhibitors of HDAC and/or EZH2
PI. Prof. Dr. Nguyen Hai Nam - MS: 104.01-2023.17 – Level: Nafosted - Time: 2024 – 2027
[2] Developing a multitarget anti-gout agent from Gnetum montanum using network pharmacology and molecular docking
PI. Assoc. Prof. Dr. Nguyen Thuy Duong - MS: 108.05-2023.23 – Level: Nafosted - Time: 2024 – 2027
[3] HILIC-HRMS analysis of oligosaccharide fragment mapping and sequencing for assessment of biosimilar enoxaparin
PI. Dr. Vu Ngan Binh - MS: 108.06-2023.05 – Level: Nafosted - Time: 2024 – 2027
[4] Establishment of lipolysis model and in-vitro in vivo correlation to determine liberation and absorption of low bioavailability drugs from lipid-based drug delivery systems
PI. Assoc. Prof. Dr. Nguyen Thach Tung - MS: 108.05-2023.01 – Level: Nafosted - Time: 2024 – 2027
[5] Research on formulation, evaluation and application of multi-particle system in prolonged release, taste masking and fixed dose combination of drugs
PI. Assoc. Prof. Dr. Nguyen Hoang Anh - MS: NCUD.03-2023.03 – Level: Nafosted - Time: 2024 – 2027
2023 (03)
[1] Development of Nano eye drops and controlled drug release system containing Mangiferin for the treatment of herpes virus keratitis
PI. Dr. Vo Quoc Anh - MS: NCUD.NCUD.03-2022.01 – Level: Nafosted - Time: 2023 – 2026
[2] Design, synthesis and bioevaluation of novel 2-oxoindoline derivaives as anticancer and anti-Alzheimer agents
PI. Dr. Do Mai Dung - MS: 104.01-2021.08 – Level: Nafosted - Time: 2023 – 2026
[3] Mechanism to eradicate persistence S. aureus in biofilm of some medicinal plants in Vietnam
PI. Dr. Nguyen Khac Tiep - MS: 108.06-2021.31 – Level: Nafosted - Time: 2023 – 2026
2020 (06)
[1] Design, synthesis and evaluation of antitumor activity of novel heterocycle-based N-hydroxyacrylamides as histone deacetylase inhibitors
PI. Assoc. Prof. Dr. Dao Thi Kim Oanh - MS: 104.01-2020.19 – Level: Nafosted - Time: 2020 – 2023
[2] Discovery and development of potential immunomodulatory anti-cancer agents as Indoleamine 2,3-dioxygenase 1 inhibitors
PI. Dr. Tran Phuong Thao - MS: 108.05-2020.01 – Level: Nafosted - Time: 2020 – 2023
[3] Method development for detection of synthetic phosphodiesterase-5 inhibitors adulterated in herbal products using thin-layer chromatography coupled with surface enhanced Raman spectroscopy (TLC-SERS)
PI. Assoc. Prof. Dr. Pham Thi Thanh Ha - MS: 104.04-2020.29 – Level: Nafosted - Time: 2020 – 2023
[4 Assessing the consumption of antibiotics and addictive drugs including alcohol and tobacco in Hanoi using wastewater analysis
PI. Assoc. Prof. Dr. Nguyen Thi Kieu Anh - MS: 105.99-2020.22 – Level: Nafosted - Time: 2020 – 2023
[5] Design, synthesis and evaluation of antitumor activity of several new series hybridized N-arylidenecarbamoylacetohydrazides as potential caspase activating agents and/or tubulin inhibitors
PI. Assoc. Prof. Dr. Phan Thi Phuong Dung - MS: 104.01-2019.300 – Level: Nafosted - Time: 2020 – 2023
[6] Investigation of precipitation and supersaturation of poorly soluble drugs applied in preparation of nanocrystal and amorphous solid dispersion to enhance the drugs bioavailability.
PI. Assoc. Prof. Dr. Nguyen Thach Tung - MS: 108.05-2019.300 – Level: Nafosted - Time: 2020 – 2022
13-10-2025
